FindTrial
Sign In

A study of gut microbiome in Indian children with type 1 diabetes

A study of gut micro-biome in Indian children with type 1 diabetes - Gut Microbiome study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035871
Enrollment
60
Registered
2021-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E109- Type 1 diabetes mellitus without complications

Interventions

Intervention1: Prebiotic Supplementation: Inulin enriched with oligosaccharide fructose will be given to a diabetic group for 3 months intervention period Control Intervention1: Placebo control: Malto

Sponsors

Hirabai Cowasji Jehangir Medical Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Diabetes Detected at least for 1 year 2)Signed consent and assent forms

Exclusion criteria

Exclusion criteria: 1) Abnormal Hemoglobin levels less than 10 g/dl 2)Antibiotic taken in last 3 months 3)Co-morbidities like Gluten sensitivity, diarrhea in last 1 month, Celiac diseases, uncontrolled autoimmune thyroiditis 4)Not signed consent and assent forms 5)Allergy or any other medication

Design outcomes

Primary

MeasureTime frame
height,weight,Glycated hemoglobin (HbA1c) levels gut micro-biome will be altered after supplementation trialTimepoint: Baseline and Endline—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactDr Vaman Khadilkar

Hirabai Cowasji Jehangir Medical Research Institute

vamankhadilkar@gmail.com9850244305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026